Performance evaluation and reference interval establishment of Abbott Alinity thyroid-stimulating hormone receptor antibody (TRAb) assay for diagnosing Graves’ disease
This study demonstrated the robustness of Abbott Alinity TRAb CMIA in clinical use with its verified analytical and clinical performance and established the reference interval for Chinese population.
Authors
- Yaoming Yan
- Yong Xia
- Bowen Li
- Jize Lao
- Junhan Zhao
- Hao Xue
- Ling Ji
Institutions
- Abbott (China) (CN)
- Peking University Shenzhen Hospital (CN)
Publication Details
- Journal
- PLoS ONE
- Published
- 2026-02-04
- DOI
- https://doi.org/10.1371/journal.pone.0339494
- Primary Topic
- Thyroid Disorders and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00